Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight loss drugs Mounjaro and Zepbound, in a matter of days. That’s because a ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

The offer may show employers how hard drug manufacturers will compete based on price, in at least some situations.

One of the many ways Hill’s Clinic Pharmacy continues to serve the residents of Portage la Prairie and the surrounding area ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly's weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed decision filed ...

A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...

After being exposed to toxins from the LA fires, some firefighters are turning to a compounded breathing drug, but it's hard ...

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...